(Q80506444)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17581610%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

JAK2-V617F activating mutation in acute myeloid leukemia: prognostic impact and association with other molecular markers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17581610%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

main subject

acute myeloid leukemia

1 reference

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17581610%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Vicente C

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17581610%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Vázquez I

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17581610%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Marcotegui N

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17581610%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Conchillo A

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17581610%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Carranza C

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17581610%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Rivell G

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17581610%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Bandrés E

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17581610%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Cristobal I

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17581610%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Lahortiga I

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17581610%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Odero MD

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17581610%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

21 June 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17581610%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17581610%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17581610%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17581610%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

2386-2390

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17581610%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404812

1 January 2020

exact match

0 references

cites work

The molecular basis of leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404812

7 January 2021

Jak2: normal function and role in hematopoietic disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404812

7 January 2021

The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404812

7 January 2021

Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404812

7 January 2021

JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404812

7 January 2021

The V617F JAK2 mutation is uncommon in cancers and in myeloid malignancies other than the classic myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404812

7 January 2021

The JAK2 V617F mutation in de novo acute myelogenous leukemias.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404812

7 January 2021

Rare occurrence of the JAK2 V617F mutation in AML subtypes M5, M6, and M7.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404812

7 January 2021

JAK2 V617F is a rare finding in de novo acute myeloid leukemia, but STAT3 activation is common and remains unexplained

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404812

7 January 2021

Mutations of N-RAS, FLT3 and p53 genes are not involved in the development of acute leukemia transformed from myeloproliferative diseases with JAK2 mutation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404812

7 January 2021

JAK2 seems to be a typical cooperating mutation in therapy-related t(8;21)/ AML1-ETO-positive AML

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404812

7 January 2021

JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404812

7 January 2021

JAK signaling globally counteracts heterochromatic gene silencing

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404812

7 January 2021

V617F mutation in JAK2 is associated with poorer survival in idiopathic myelofibrosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404812

7 January 2021

Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations, and role in leukemic transformation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404812

7 January 2021

Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404812

7 January 2021

Association between acquired uniparental disomy and homozygous gene mutation in acute myeloid leukemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404812

7 January 2021

dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity data

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404812

7 January 2021